STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRNA
  4. [Form 4] Moderna, Inc. Insider Trading Activity

Moderna (MRNA) director converts 4,058 RSUs into common stock

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Moderna director Elizabeth E. Tallett exercised restricted stock units into common shares. On April 30, 2026, 4,058 restricted stock units converted into 4,058 shares of Moderna common stock at an exercise price of $0.00 per share. Following this transaction, she directly holds 4,761 common shares. The restricted stock unit award vested in full on April 30, 2026, and the filing shows no remaining derivative position tied to this award.

Positive

  • None.

Negative

  • None.
Insider Tallett Elizabeth E
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 4,058 $0.00 --
Exercise Common Stock 4,058 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 4,761 shares (Direct, null)
Footnotes (1)
  1. Restricted stock units convert into common stock on a one-for-one basis. The shares subject to this restricted stock unit award vested in full on April 30, 2026.
RSUs exercised 4,058 units Restricted stock units converted to common stock on April 30, 2026
Shares received 4,058 shares Common stock issued upon RSU conversion on April 30, 2026
Exercise price $0.00 per share Conversion price for RSUs into Moderna common stock
Shares held after transaction 4,761 shares Director’s direct Moderna common stock holdings after April 30, 2026
Derivative position remaining 0 units Restricted stock units remaining after full vesting and conversion
Restricted Stock Units financial
"The shares subject to this restricted stock unit award vested in full on April 30, 2026."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
convert into common stock on a one-for-one basis financial
"Restricted stock units convert into common stock on a one-for-one basis."
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tallett Elizabeth E
(Last)(First)(Middle)
C/O MODERNA, INC.
325 BINNEY STREET
(Street)
CAMBRIDGE MASSACHUSETTS 02142
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Moderna, Inc. [ MRNA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/30/2026M(1)4,058A(1)4,761D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)04/30/2026M(1)4,058 (2) (2)Common Stock4,058$00D
Explanation of Responses:
1. Restricted stock units convert into common stock on a one-for-one basis.
2. The shares subject to this restricted stock unit award vested in full on April 30, 2026.
/s/ James Dillon, as Attorney-in-Fact05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Moderna (MRNA) report for Elizabeth E. Tallett?

Moderna reported that director Elizabeth E. Tallett exercised 4,058 restricted stock units into 4,058 common shares. The units vested in full on April 30, 2026, and converted on a one-for-one basis at $0.00 per share.

How many Moderna (MRNA) shares does Elizabeth E. Tallett hold after this Form 4?

After the reported transaction, Elizabeth E. Tallett directly holds 4,761 shares of Moderna common stock. This reflects the addition of 4,058 shares from restricted stock units that vested and converted on April 30, 2026.

What happened to the 4,058 restricted stock units in the Moderna (MRNA) filing?

The 4,058 restricted stock units vested in full and converted into 4,058 Moderna common shares on April 30, 2026. After conversion, the restricted stock unit position shown in the filing is reduced to zero shares outstanding.

Was there a sale of Moderna (MRNA) shares in this insider transaction?

The filing shows no sale of Moderna shares. It reports only the exercise and conversion of 4,058 restricted stock units into common stock, leaving Elizabeth E. Tallett with 4,761 directly held common shares after the transaction.

At what price did the Moderna (MRNA) restricted stock units convert to common stock?

The 4,058 restricted stock units converted into Moderna common stock at $0.00 per share. This reflects the typical structure of restricted stock units, which convert into shares without additional cash payment when vesting conditions are met.